SEC Former Precipio CFO, Son Agree to Settle SEC Insider Trading Lawsuit Former Precipio CFO Carl Iberger was charged with providing confidential information regarding a company distribution deal for a COVID-19 test. CareDx Q3 Revenues Grow 42 Percent; Firm Discloses Investigations by DOJ, SEC The molecular diagnostics company reported $75.6 million in revenues for the quarter and said testing service revenues rose 46 percent year over year. Cue Health Files for IPO for up to $100M The company developed its portable Cue Integrated Care Platform for molecular SARS-CoV-2 testing and received an EUA for its test in June 2020. Talis Biomedical 2020 Revenues Rise Sharply The company also said it is planning on filing for Emergency Use Authorization for its SARS-CoV-2 test in the second quarter of 2021. SEC Sues Founders of Bankrupt Human Microbiome Testing Firm uBiome For Fraud The US Securities and Exchange Commission alleges that uBiome's founders misled investors in order to close a Series C financing round in 2018. Nov 13, 2020 Abbott Enters $5B Credit Agreement Sep 11, 2020 Hologic Raises Q4 Revenue Guidance Sep 9, 2020 Early Cancer Detection Firm Grail Files for IPO Aug 20, 2020 Aiming to Put Regulatory, Payor Issues in Past, Progenity Progresses With Women's Health Pipeline Premium Jun 16, 2020 Progenity Eyes $122.6M in Amended IPO Jun 15, 2020 Genetron Health Targeting $175.5M in Amended US IPO Jun 10, 2020 Danaher Replaces Previous $5B Credit Facility with New $2.5B Facility Jun 7, 2020 ArcherDx Targeting $100M in IPO Apr 27, 2020 SeqLL Withdraws Plans for $8M IPO Feb 12, 2020 OpGen Preliminary 2019 Revenues up 19 Percent Jan 24, 2020 Adaptive Biotechnologies Prices Public Offering of Stock Dec 17, 2019 Grail Raises $125M in Equity Financing Offering Dec 2, 2019 Genetron Health Gets China NMPA Approval for Clinical NGS System, Files for IPO Oct 15, 2019 OpGen Plans $10.4M Stock, Warrant Sale Sep 4, 2019 Danaher Offering €6.20B in Senior Notes Aug 30, 2019 Danaher Enters Into $10B Loan Agreements Aug 28, 2019 OpGen Plans Reverse Stock Split Aug 13, 2019 Fulgent Genetics to Offer $75M of Securities Jul 10, 2019 Former Illumina Accountant Pleads Guilty to Insider Trading Mar 6, 2019 Invitae Expects to Raise at Least $171M in Common Stock Offering Load More Breaking News Mitochondrial Protein Resource Reveals New Disease Players StageZero Life Sciences, DiagnoseAtHome Partner on Multicancer Blood Test OraSure Technologies Selected by HHS to Provide COVID-19 School Testing Hologic Obtains CE Mark for Molecular Epstein-Barr, BK Virus Assays Multiomics Startup Pleno Closes $15M Funding Round SeekIn Gets CE Mark for Cancer Treatment Response Monitoring Kit The Scan UK Moves to Allow Sale of Gene-Edited Food The UK is moving ahead to allow the sale of gene-edited food in England, Scotland, and Wales, according to New Scientist. Questions for the Field Stat News writes that the alleged Buffalo shooter's citation of genetics research raises questions about what the field can do. Cell Studies on Tumor Evolution in Mouse Model of Lung Cancer, Stereo-seq, Bacteriophage Responses In Cell this week: tumor evolution tracked in mouse model of lung cancer, organogenesis mapped using Stereo-seq, and more. Taking Stock of the Stockpile The US and European countries are evaluating their smallpox vaccine stockpiles as the number of monkeypox cases increases, the Washington Post reports.